Trading update

RNS Number : 4295O

EKF Diagnostics Holdings PLC

07 November 2016

 

EKF Diagnostics Holdings plc

("EKF", the "Company")

Trading update

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that early trading in Q4 of the current financial year has again been materially higher than budget and at a run-rate in excess of already revised market forecasts, upgraded following the trading update provided on 7 October 2016.

The Company now believes that it will achieve revenues of at least £36.5m and adjusted EBITDA for the year ending 31 December 2016 of at least £5.5m, therefore exceeding current market forecasts. The strong performance of the business is due to organic growth.

In addition, the Company announces that cash generation continues to be strong and now expects to be close to breakeven if not cash positive by the year end, and then cash positive in the first quarter, again ahead of the board's previous expectations.

The announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

EKF Diagnostics Holdings plc	www.ekfdiagnostics.com
Christopher Mills, Non-Executive Chairman	Tel: [phone]
Julian Baines, CEO
Richard Evans, FD & COO
Panmure Gordon (UK) Limited (NOMAD & Joint Broker)	Tel: [phone]
Freddy Crossley / Peter Steel (Corporate Finance)
N+1 Singer (Joint Broker)	Tel: [phone]
Alex Price / Alex Laughton-Scott
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus / Lianne Cawthorne	Mob: [phone]

 

END

 

 

TSTLLFIDLALSIIR